Daniel Welch's most recent trade in Structure Therapeutics Inc - ADR was a trade of 39,453 Share Option (right to buy) done . Disclosure was reported to the exchange on June 17, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Structure Therapeutics Inc (ADR) | Mr. Daniel G. Welch | Director | 17 Jun 2026 | 39,453 | 39,453 | - | - | Share Option (right to buy) | ||
| Prothena Corporation plc | Mr. Daniel G. Welch | Director | 15 May 2026 | 27,000 | 27,000 | - | - | Stock Option (Right to Buy) | ||
| Ultragenyx Pharmaceutical Inc | Mr. Daniel G. Welch | Director | 14 May 2026 | 14,058 | 14,058 | - | - | Stock Option (Right to Buy) | ||
| Ultragenyx Pharmaceutical Inc | Mr. Daniel G. Welch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2026 | 7,751 | 40,441 (0%) | 0% | 0 | Common Stock | |
| Structure Therapeutics Inc (ADR) | Mr. Daniel G. Welch | Director | 23 Jun 2025 | 51,804 | 51,804 | - | - | Share Option (right to buy) | ||
| Ultragenyx Pharmaceutical Inc | Mr. Daniel G. Welch | Director | 15 May 2025 | 10,787 | 10,787 | - | - | Stock Option (Right to Buy) | ||
| Ultragenyx Pharmaceutical Inc | Mr. Daniel G. Welch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2025 | 5,740 | 32,690 (0%) | 0% | 0 | Common Stock | |
| Ultragenyx Pharmaceutical Inc | Mr. Daniel G. Welch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2025 | 5,740 | 32,690 (0%) | 0% | 0 | - | |
| Prothena Corporation plc | Mr. Daniel G. Welch | Director | 14 May 2025 | 20,183 | 20,183 | - | - | Stock Option (Right to Buy) | ||
| Structure Therapeutics Inc (ADR) | Mr. Daniel G. Welch | Director | 25 Jun 2024 | 37,500 | 37,500 | - | - | Share Option (right to buy) | ||
| Ultragenyx Pharmaceutical Inc | Mr. Daniel G. Welch | Director | 18 Jun 2024 | 9,900 | 9,900 | - | - | Stock Option (Right to Buy) | ||
| Ultragenyx Pharmaceutical Inc | Mr. Daniel G. Welch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2024 | 5,345 | 26,950 (0%) | 0% | 0 | Common Stock | |
| Nuvation Bio Inc (Class A) | Mr. Daniel G. Welch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.64 per share. | 24 May 2024 | 366,744 | 659,947 | - | 1.6 | 601,460 | Class A Common Stock |
| Nuvation Bio Inc (Class A) | Mr. Daniel G. Welch | Director | 24 May 2024 | 366,744 | 0 | - | - | Stock Option (Right to Buy) | ||
| Nuvation Bio Inc (Class A) | Mr. Daniel G. Welch | Director | 24 May 2024 | 293,203 | 19,547 | - | - | Stock Option (Right to Buy) | ||
| Nuvation Bio Inc (Class A) | Mr. Daniel G. Welch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.74 per share. | 24 May 2024 | 293,203 | 293,203 | - | 1.7 | 510,173 | Class A Common Stock |
| Prothena Corporation plc | Mr. Daniel G. Welch | Director | 15 May 2024 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | ||
| Prothena Corporation plc | Mr. Daniel G. Welch | Director | 21 Feb 2024 | 132,000 | 132,000 | - | - | Stock Option (Right to Buy) | ||
| Seagen Inc | Daniel G. Welch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 135.63 per share. | 28 Aug 2023 | 1,812 | 10,109 (0%) | 0% | 135.6 | 245,762 | Common Stock |
| Seagen Inc | Daniel G. Welch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Aug 2023 | 1,812 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Seagen Inc | Daniel G. Welch | Director | Sale of securities on an exchange or to another person at price $ 209.01 per share. | 28 Aug 2023 | 1,812 | 6,794 (0%) | 0% | 209.0 | 378,726 | Common Stock |
| Seagen Inc | Daniel G. Welch | Director | Sale of securities on an exchange or to another person at price $ 209.08 per share. | 28 Aug 2023 | 1,610 | 10,725 (0%) | 0% | 209.1 | 336,619 | Common Stock |
| Seagen Inc | Daniel G. Welch | Director | Sale of securities on an exchange or to another person at price $ 209.16 per share. | 28 Aug 2023 | 1,503 | 8,606 (0%) | 0% | 209.2 | 314,367 | Common Stock |
| Ultragenyx Pharmaceutical Inc | Mr. Daniel G. Welch | Director | 07 Jun 2023 | 7,110 | 7,110 | - | - | Stock Option (Right to Buy) | ||
| Ultragenyx Pharmaceutical Inc | Mr. Daniel G. Welch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 3,860 | 21,605 (0%) | 0% | 0 | Common Stock | |
| Seagen Inc | Daniel G. Welch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 2,044 | 8,297 (0%) | 0% | 0 | Common Stock | |
| Nuvation Bio Inc (Class A) | Mr. Daniel G. Welch | Director | 15 May 2023 | 366,744 | 366,744 | - | - | Stock Option (Right to Buy) | ||
| Seagen Inc | Daniel G. Welch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2023 | 1,864 | 1,812 | - | - | Non-Qualified Stock Option (right to buy) | |
| Seagen Inc | Daniel G. Welch | Director | Sale of securities on an exchange or to another person at price $ 200.02 per share. | 15 May 2023 | 1,864 | 6,253 (0%) | 0% | 200.0 | 372,837 | Common Stock |
| Seagen Inc | Daniel G. Welch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 135.63 per share. | 15 May 2023 | 1,864 | 8,117 (0%) | 0% | 135.6 | 252,814 | Common Stock |
| Seagen Inc | Daniel G. Welch | Director | Sale of securities on an exchange or to another person at price $ 200.07 per share. | 01 May 2023 | 5,835 | 12,335 (0%) | 0% | 200.1 | 1,167,408 | Common Stock |
| Seagen Inc | Daniel G. Welch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 64.38 per share. | 01 May 2023 | 5,150 | 12,049 (0%) | 0% | 64.4 | 331,557 | Common Stock |
| Seagen Inc | Daniel G. Welch | Director | Sale of securities on an exchange or to another person at price $ 200.04 per share. | 01 May 2023 | 5,150 | 6,899 (0%) | 0% | 200.0 | 1,030,206 | Common Stock |
| Seagen Inc | Daniel G. Welch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2023 | 5,150 | 1,888 | - | - | Non-Qualified Stock Option (right to buy) | |
| Seagen Inc | Daniel G. Welch | Director | Sale of securities on an exchange or to another person at price $ 200.06 per share. | 01 May 2023 | 4,890 | 18,170 (0%) | 0% | 200.1 | 978,293 | Common Stock |
| Seagen Inc | Daniel G. Welch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2023 | 3,462 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Seagen Inc | Daniel G. Welch | Director | Sale of securities on an exchange or to another person at price $ 200.10 per share. | 01 May 2023 | 3,462 | 6,604 (0%) | 0% | 200.1 | 692,746 | Common Stock |
| Seagen Inc | Daniel G. Welch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 147.50 per share. | 01 May 2023 | 3,462 | 10,066 (0%) | 0% | 147.5 | 510,645 | Common Stock |
| Seagen Inc | Daniel G. Welch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2023 | 3,171 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Seagen Inc | Daniel G. Welch | Director | Sale of securities on an exchange or to another person at price $ 200.05 per share. | 01 May 2023 | 3,171 | 6,604 (0%) | 0% | 200.1 | 634,359 | Common Stock |
| Seagen Inc | Daniel G. Welch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 160.33 per share. | 01 May 2023 | 3,171 | 9,775 (0%) | 0% | 160.3 | 508,406 | Common Stock |
| Seagen Inc | Daniel G. Welch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2023 | 1,990 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Seagen Inc | Daniel G. Welch | Director | Sale of securities on an exchange or to another person at price $ 200.12 per share. | 01 May 2023 | 1,990 | 6,899 (0%) | 0% | 200.1 | 398,239 | Common Stock |
| Seagen Inc | Daniel G. Welch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 56.77 per share. | 01 May 2023 | 1,990 | 8,889 (0%) | 0% | 56.8 | 112,972 | Common Stock |
| Seagen Inc | Daniel G. Welch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2023 | 1,888 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Seagen Inc | Daniel G. Welch | Director | Sale of securities on an exchange or to another person at price $ 200.05 per share. | 01 May 2023 | 1,888 | 6,604 (0%) | 0% | 200.0 | 377,694 | Common Stock |
| Seagen Inc | Daniel G. Welch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 64.38 per share. | 01 May 2023 | 1,888 | 8,492 (0%) | 0% | 64.4 | 121,549 | Common Stock |
| Seagen Inc | Daniel G. Welch | Director | Sale of securities on an exchange or to another person at price $ 200.07 per share. | 01 May 2023 | 351 | 6,253 (0%) | 0% | 200.1 | 70,225 | Common Stock |
| Seagen Inc | Daniel G. Welch | Director | Sale of securities on an exchange or to another person at price $ 200.06 per share. | 01 May 2023 | 295 | 6,604 (0%) | 0% | 200.1 | 59,018 | Common Stock |
| Seagen Inc | Daniel G. Welch | Director | Sale of securities on an exchange or to another person at price $ 200.05 per share. | 15 Mar 2023 | 2,037 | 7,219 (0%) | 0% | 200.1 | 407,502 | Common Stock |
| Seagen Inc | Daniel G. Welch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2023 | 2,037 | 995 | - | - | Non-Qualified Stock Option (right to buy) | |
| Seagen Inc | Daniel G. Welch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 38.82 per share. | 15 Mar 2023 | 2,037 | 9,256 (0%) | 0% | 38.8 | 79,076 | Common Stock |
| Seagen Inc | Daniel G. Welch | Director | Sale of securities on an exchange or to another person at price $ 200.05 per share. | 15 Mar 2023 | 1,246 | 23,060 (0%) | 0% | 200.0 | 249,262 | Common Stock |
| Seagen Inc | Daniel G. Welch | Director | Sale of securities on an exchange or to another person at price $ 200.05 per share. | 15 Mar 2023 | 320 | 6,899 (0%) | 0% | 200.1 | 64,016 | Common Stock |
| Seagen Inc | Daniel G. Welch | Director | Sale of securities on an exchange or to another person at price $ 200.20 per share. | 13 Mar 2023 | 8,210 | 25,575 (0%) | 0% | 200.2 | 1,643,642 | Common Stock |
| Seagen Inc | Daniel G. Welch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Mar 2023 | 7,629 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Seagen Inc | Daniel G. Welch | Director | Sale of securities on an exchange or to another person at price $ 200.30 per share. | 13 Mar 2023 | 7,629 | 15,407 (0%) | 0% | 200.3 | 1,528,089 | Common Stock |
| Seagen Inc | Daniel G. Welch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 39.94 per share. | 13 Mar 2023 | 7,629 | 23,036 (0%) | 0% | 39.9 | 304,702 | Common Stock |
| Seagen Inc | Daniel G. Welch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Mar 2023 | 5,758 | 3,502 | - | - | Non-Qualified Stock Option (right to buy) | |
| Seagen Inc | Daniel G. Welch | Director | Sale of securities on an exchange or to another person at price $ 200.06 per share. | 13 Mar 2023 | 5,758 | 7,219 (0%) | 0% | 200.1 | 1,151,945 | Common Stock |
| Seagen Inc | Daniel G. Welch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 38.82 per share. | 13 Mar 2023 | 5,758 | 15,407 (0%) | 0% | 38.8 | 223,526 | Common Stock |
| Seagen Inc | Daniel G. Welch | Director | Sale of securities on an exchange or to another person at price $ 200.20 per share. | 13 Mar 2023 | 2,098 | 13,309 (0%) | 0% | 200.2 | 420,020 | Common Stock |
| Seagen Inc | Daniel G. Welch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Mar 2023 | 1,348 | 7,629 | - | - | Non-Qualified Stock Option (right to buy) | |
| Seagen Inc | Daniel G. Welch | Director | Sale of securities on an exchange or to another person at price $ 201.53 per share. | 13 Mar 2023 | 1,348 | 15,407 (0%) | 0% | 201.5 | 271,662 | Common Stock |
| Seagen Inc | Daniel G. Welch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 39.94 per share. | 13 Mar 2023 | 1,348 | 16,755 (0%) | 0% | 39.9 | 53,839 | Common Stock |
| Seagen Inc | Daniel G. Welch | Director | Sale of securities on an exchange or to another person at price $ 201.53 per share. | 13 Mar 2023 | 808 | 24,767 (0%) | 0% | 201.5 | 162,836 | Common Stock |
| Seagen Inc | Daniel G. Welch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Mar 2023 | 470 | 3,032 | - | - | Non-Qualified Stock Option (right to buy) | |
| Seagen Inc | Daniel G. Welch | Director | Sale of securities on an exchange or to another person at price $ 200.00 per share. | 13 Mar 2023 | 470 | 12,977 (0%) | 0% | 200 | 94,000 | Common Stock |
| Seagen Inc | Daniel G. Welch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 38.82 per share. | 13 Mar 2023 | 470 | 13,447 (0%) | 0% | 38.8 | 18,245 | Common Stock |
| Seagen Inc | Daniel G. Welch | Director | Sale of securities on an exchange or to another person at price $ 200.00 per share. | 13 Mar 2023 | 288 | 24,306 (0%) | 0% | 200 | 57,600 | Common Stock |
| Seagen Inc | Daniel G. Welch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Mar 2023 | 283 | 8,977 | - | - | Non-Qualified Stock Option (right to buy) | |
| Seagen Inc | Daniel G. Welch | Director | Sale of securities on an exchange or to another person at price $ 202.36 per share. | 13 Mar 2023 | 283 | 15,407 (0%) | 0% | 202.4 | 57,268 | Common Stock |
| Seagen Inc | Daniel G. Welch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 39.94 per share. | 13 Mar 2023 | 283 | 15,690 (0%) | 0% | 39.9 | 11,303 | Common Stock |
| Seagen Inc | Daniel G. Welch | Director | Sale of securities on an exchange or to another person at price $ 201.53 per share. | 13 Mar 2023 | 214 | 13,095 (0%) | 0% | 201.5 | 43,127 | Common Stock |
| Seagen Inc | Daniel G. Welch | Director | Sale of securities on an exchange or to another person at price $ 202.36 per share. | 13 Mar 2023 | 173 | 24,594 (0%) | 0% | 202.4 | 35,008 | Common Stock |
| Seagen Inc | Daniel G. Welch | Director | Sale of securities on an exchange or to another person at price $ 200.00 per share. | 13 Mar 2023 | 74 | 12,977 (0%) | 0% | 200 | 14,800 | Common Stock |
| Seagen Inc | Daniel G. Welch | Director | Sale of securities on an exchange or to another person at price $ 202.34 per share. | 13 Mar 2023 | 44 | 13,051 (0%) | 0% | 202.3 | 8,903 | Common Stock |
| Structure Therapeutics Inc (ADR) | Mr. Daniel G. Welch | Director | 07 Feb 2023 | 123,508 | 123,508 | - | - | - | ||
| Ultragenyx Pharmaceutical Inc | Mr. Daniel G. Welch | Director | 24 Jun 2022 | 6,245 | 6,245 | - | - | Stock Option (Right to Buy) | ||
| Ultragenyx Pharmaceutical Inc | Mr. Daniel G. Welch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2022 | 3,300 | 17,745 (0%) | 0% | 0 | Common Stock | |
| Nuvation Bio Inc (Class A) | Mr. Daniel G. Welch | Director | 16 May 2022 | 140,713 | 140,713 | - | - | Stock Option (Right to Buy) | ||
| Seagen Inc | Daniel G. Welch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2022 | 3,676 | 3,676 | - | - | Non-Qualified Stock Option (right to buy) | |
| Seagen Inc | Daniel G. Welch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2022 | 1,503 | 9,649 (0%) | 0% | 0 | Common Stock | |
| Waters | Mr. Daniel Welch | SVP Global Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 306.53 per share. | 23 Feb 2022 | 34 | 2,847 (0%) | 0% | 306.5 | 10,422 | Common Stock |
| Waters | Mr. Daniel Welch | SVP Global Operations | 17 Feb 2022 | 3,974 | 3,974 | - | - | Stock Option (Right to Buy) | ||
| Waters | Mr. Daniel Welch | SVP Global Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 315.00 per share. | 17 Feb 2022 | 22 | 2,881 (0%) | 0% | 315 | 6,930 | Common Stock |